| abstract |
In certain embodiments, the invention includes a method of treating solid tumor cancer by modulating a tumor microenvironment using a BTK inhibitor, including macrophages, mononuclear cells, mast cells, helper T cells, cells Toxic T cells, regulatory T cells, natural killer cells, bone marrow-derived suppressor cells, regulatory B cells, neutrophils, dendritic cells, and fibroblasts. |